Search

everythinglearnresearchcommunity

for

Search:↓

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

ILC1 cells contribute to hair loss in alopecia areata.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Red ginseng oil is believed to have various health benefits and is safe, but more research is needed to fully understand how it works.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Radiation damages salivary glands by harming blood vessels, but antioxidants might help protect them.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Broussonetia papyrifera extract helps hair growth by regulating specific proteins.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.